ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Acute Tubular and Glomerular Kidney Injury Markers Reflect Ischemia-Reperfusion and Rejection

    Y. Shim, R. Fan, N. Dvorina, W. Baldwin.

    Immunology, Cleveland Clinic, Cleveland, OH.

    Reliable markers of early acute injury following renal transplantation would enable timely therapeutic interventions. Standard serum creatinine and blood urea nitrogen measurements increase only after…
  • 2018 American Transplant Congress

    Multiple Factors Contribute to an Expanded Immune Risk Profile in Pre Renal Transplant Candidates

    D. DeWolfe,1 K. McGann,1 J. Ghofrani,1 E. Geiger,1 C. Helzer,1 S. Kleiboeker,2 S. Jost,1 C. Tan.1

    1Medicine, Beth Israel Deaconess Medical Center, Boston, MA; 2Viracor-Eurofins, Lee's Summmit, MO.

    Introduction: Older renal transplant recipients have a lower risk of rejection, but are at increased risk for infectious complications. An immune risk profile (IRP) has…
  • 2018 American Transplant Congress

    Involvement of Aldehyde Dehydrogenase 2 (ALDH2) in Fatty Liver Graft Protection Mechanisms against Cold Ischemic Injury

    A. Panisello-Rosello,1 A. Lopez,2 C. Castro,2 S. Bellogi,1 E. Folch-Puy,1 A. Rolo,3 C. Palmeira,3 R. Adam, J. Roselló-Catafau.

    1Experimental Pathology, Instituto de Investigaciones Biomédicas de Barcelona, Barcelona, Catalonia, Spain; 2INSERM U935, Hôpital Paul Brousse, Paris, France; 3Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.

    Aldehyde dehydogenase (ALDH2) is a mitochondrial enzyme that recently has been involved in the cardioprotection against ischemia injury. No data are reported on the potential…
  • 2018 American Transplant Congress

    Dynamics of CD25-Positive Myeloid Suppressor Cells in Solid Organ Transplanted Patients and Relationship with Rejection

    A. Utrero-Rico,1 R. Laguna-Goya,1 F. Cano-Romero,1 E. Gómez-Massa,2 M. Fernandez-Ruiz,3 J. Aguado,3 E. Mancebo-Sierra,2 M. Castro-Panete,2 E. Paz-Artal.1,2

    1Immunodeficiencies and Transplant Immunology Group, Research Institute of Hospital 12 de Octubre (i+12), Madrid, Spain; 2Immunology, Hospital 12 de Octubre, Madrid, Spain; 3Infectious Diseases, Hospital 12 de Octubre, Madrid, Spain.

    Background: Myeloid derived suppressor cells (MDSC) are immature cells with immunosuppressive capacities. Three MDSC subsets are currently defined: monocytic, early stage, and polymorphonuclear MDSC (M-MDSC,…
  • 2018 American Transplant Congress

    Leukocytes from Recipients with Severe Primary Graft Dysfunction after Lung Transplant Adoptively Transfer Alloreactivity to Vessel Grafts Trans Vivo

    A-.K. Knoefel,1 T. Siemeni,1 N. Madrahimov,1 W. Sommer,1 M. Avsar,1 L. Ahrens,1 I. Tudorache,1 A. Haverich,1 C. Falk,2 G. Warnecke.1

    1HTTG, MHH, Hannover, Germany; 2Transplantimmunology, MHH, Hannover, Germany.

    Introduction: Primary graft dysfunction (PGD) is the main cause of early mortality after lung transplantation (LTx). Multiple mechanisms have been described, but the link between…
  • 2018 American Transplant Congress

    Hyperglycemia-Triggered S1P/SIPR3signaling Exacerbates Liver Ischemia/Reperfusion Injury by Regulating M1/M2 Polarization

    J. Rao,1,2 Y. Hu,1 C. Yang,1 S. Yang,1 F. Cheng,1 F. Zhang,1 X. Wang,1 Y. Zhai,1,2 L. Lu.1,2

    1Department of Liver Surgery/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China; 2Division of Liver and Pancreas Transplantation, Department of Surgery, David Geffen School of Medicine at University of California Los Angeles, Los Angeles.

    Background and Aims: Hyperglycemia/Diabetes is an adverse risk factor for hepatic ischemia/reperfusion injury (IRI) during liver transplantation or hepatectomy; however, the underlying mechanism remains unclear.Sphingosine…
  • 2018 American Transplant Congress

    Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

    D. Chen, J. Chen.

    Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

    Background: Since acute rejection remains one of the major complications which necessitate periodic surveillance, noninvasive diagnostic/prognostic methods are preferred by renal transplant recipients. Here we…
  • 2018 American Transplant Congress

    Waning Enthusiasm for a Once Promising Test: C1q Testing Does Not Provide Prognostic Information for DSA Screening Protocols

    A. Gilbert, D. Li, M. Awwad, S. Rosen-Bronson, P. Abrams, J. Verbesey, G. Vranic, M. Cooper.

    Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC.

    Introduction: Testing of donor specific antibodies (DSA) for binding of complement component C1q has been used to better elucidate pathologic antibodies from more benign reactions.…
  • 2018 American Transplant Congress

    ABO-Incompatibility Lower Incidence of DSA-Induced Antibody-Mediated Rejection

    D. Lee,1 B. Kim,1 J. KIm,1 I. KIm,1 M. Jeon.1

    1Nephrology, Medicine, Maryknoll General Hospital, Busan, Republic of Korea; 2Laboratory Medicine, Maryknoll General Hospital, Busan, Republic of Korea; 3Surgery, Maryknoll General Hospital, Busan, Republic of Korea; 4Urology, Maryknoll General Hospital, Busan, Republic of Korea; 5Pathology, Maryknoll General Hospital, Busan, Republic of Korea.

    Introduction:Donor-specific anti-HLA antibody (DSA) and Anti-ABO antibody are major barriers for successful kidney transplantation. Limited data are available about the existences of both DSA and…
  • 2018 American Transplant Congress

    Delayed Graft Function in Live Donor HLA-Incompatible Kidney Transplant Recipients: A Multicenter Study

    J. Motter,1 A. Massie,1 J. Garonzik Wang,1 K. Jackson,1 X. Luo,1 A. Muzaale,1 B. Orandi,2 D. Segev.1

    1JHU, Baltimore; 2UCSF, San Francisco.

    Background: Many patients with a willing, but incompatible live donor choose to undergo incompatible live donor kidney transplantation (ILDKT) facilitated by desensitization procedures to eliminate…
  • « Previous Page
  • 1
  • …
  • 200
  • 201
  • 202
  • 203
  • 204
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences